Supplier of Premium Ingredients to the Food, Nutritional, Pet & Personal Care Industries
An 80-Year Journey in Probiotic Innovation
PROBIOTICS
STABILITY ENHANCED PROBIOTICS USING QUADRUPLE-COATED TECHNOLOGY
Nutralliance has partnered with Ildong Bioscience to bring their patented quadruple-coated strains to North America in turnkey probiotic solutions or fully customized offerings. Ildong Bioscience features a wide selection of strains that provide tangible health benefits with scientific documentation while meeting regulatory demands.
Bacillus coagulans IDCC 1201
Bacillus subtilis IDCC 1101
Bifidobacterium bifidum IDCC 4201
Bifidobacterium breve IDCC 4401
Bifidobacterium lactis IDCC 4301
Bifidobacterium longum IDCC 4101
Enterococcus faecium IDCC 2102
Lacticaseibacillus casei IDCC 3451
Lacticaseibacillus paracasei IDCC 3401
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Bacillus subtilis IDCC 1101
Bifidobacterium bifidum IDCC 4201
Bifidobacterium breve IDCC 4401
Bifidobacterium lactis IDCC 4301
Bifidobacterium longum IDCC 4101
Enterococcus faecium IDCC 2102
Lacticaseibacillus casei IDCC 3451
Lacticaseibacillus paracasei IDCC 3401
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Bifidobacterium bifidum IDCC 4201
Bifidobacterium breve IDCC 4401
Bifidobacterium lactis IDCC 4301
Bifidobacterium longum IDCC 4101
Enterococcus faecium IDCC 2102
Lacticaseibacillus casei IDCC 3451
Lacticaseibacillus paracasei IDCC 3401
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Bifidobacterium breve IDCC 4401
Bifidobacterium lactis IDCC 4301
Bifidobacterium longum IDCC 4101
Enterococcus faecium IDCC 2102
Lacticaseibacillus casei IDCC 3451
Lacticaseibacillus paracasei IDCC 3401
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Bifidobacterium lactis IDCC 4301
Bifidobacterium longum IDCC 4101
Enterococcus faecium IDCC 2102
Lacticaseibacillus casei IDCC 3451
Lacticaseibacillus paracasei IDCC 3401
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Bifidobacterium longum IDCC 4101
Enterococcus faecium IDCC 2102
Lacticaseibacillus casei IDCC 3451
Lacticaseibacillus paracasei IDCC 3401
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Lacticaseibacillus paracasei IDCC 3401
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Lacticaseibacillus rhamnosus IDCC 3201
Lactiplantibacillus plantarum IDCC 3501
Lactiplantibacillus plantarum IDCC 3501
Lactobacillus acidophilus IDCC 3302
Lactobacillus bulgaricus IDCC 3601
Lactobacillus gasseri IDCC 3101
Lactobacillus helveticus IDCC 3801
Lactobacillus johnsonii IDCC 9203
Lactoccocus lactis IDCC 2301
Ligilactoctobacillus salivarius IDCC 3551
Limosilactobacillus fermentum IDCC 3901
Limosilactobacillus reuteri IDCC 3701
Streptococcus thermophilus IDCC 2201
Lactobacillus bulgaricus IDCC 3601
Lactobacillus gasseri IDCC 3101
Lactobacillus helveticus IDCC 3801
Lactobacillus johnsonii IDCC 9203
Lactoccocus lactis IDCC 2301
Ligilactoctobacillus salivarius IDCC 3551
Limosilactobacillus fermentum IDCC 3901
Limosilactobacillus reuteri IDCC 3701
Streptococcus thermophilus IDCC 2201
Lactobacillus gasseri IDCC 3101
Lactobacillus helveticus IDCC 3801
Lactobacillus johnsonii IDCC 9203
Lactoccocus lactis IDCC 2301
Ligilactoctobacillus salivarius IDCC 3551
Limosilactobacillus fermentum IDCC 3901
Limosilactobacillus reuteri IDCC 3701
Streptococcus thermophilus IDCC 2201
Lactobacillus johnsonii IDCC 9203
Lactoccocus lactis IDCC 2301
Ligilactoctobacillus salivarius IDCC 3551
Limosilactobacillus fermentum IDCC 3901
Limosilactobacillus reuteri IDCC 3701
Streptococcus thermophilus IDCC 2201
Lactoccocus lactis IDCC 2301
Ligilactoctobacillus salivarius IDCC 3551
Limosilactobacillus fermentum IDCC 3901
Limosilactobacillus reuteri IDCC 3701
Streptococcus thermophilus IDCC 2201
Limosilactobacillus reuteri IDCC 3701
Streptococcus thermophilus IDCC 2201
Streptococcus thermophilus IDCC 2201
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
A Probiotic Skincare Breakthrough
Cera-Glow enhances ceramide production in human epidermal keratinocytes by stimulating sphingomyelinase activity.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*Clinically Proven Probiotics Blend which can improve bowel movement, gut health, and lower gastrointestinal symptoms. Its efficacy has been proven through a wide range of clinical tests, including in vitro, in vivo, and human.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
POSTBIOTICS
In the dynamic world of probiotics, spore-forming varieties stand out for their exceptional resilience and efficacy. These probiotics represent a groundbreaking shift in how we approach gut health and wellness, offering solutions that align with our body's natural processes. By understanding the unique capabilities of spore-forming probiotics, we unlock new possibilities for enhancing health and vitality.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Revolutionizing Immune Postbiotics
*The goal of RHT3201™ is to maintain a balanced immunological response in human bodies which is essential as excessive immunological responses can cause hypersensitivity reactions.
Through several studies, RHT3201™ has shown significant effects on the production of cytokines and helps to modulate the balanced immune response between Th1 and Th2. These immunomodulatory effects lead to the suppression of hypersensitivity reactions.
Enjoy immune health and gut health with the very newest ingredients.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
A New Era in Cholesterol Parabiotics
ILDONG Bioscience introduces BBR4401, a novel parabiotic recognized by Korea's KFDA for its innovative approach to health. Harnessing the power of Bifidobacterium breve IDCC 4401, this product stands at the forefront of cholesterol and gut health management.
*Exploring the Study
Delve into the groundbreaking clinical trial of BBR4401, a game-changer in cholesterol management. This in-depth study, designed as a randomized, double-blind, placebo-controlled trial, focused on adults with moderate hypercholesterolemia. Over 12 weeks, it evaluated the effects of different doses of BBR4401, a parabiotic derived from Bifidobacterium breve, agains a placebo.
*Discovering the Results
The study's remarkable findings showcased significant reductions in LDL-cholesterol levels among participants receiving BBR4401, highlighting its efficacy. Furthermore, the careful assessment of BBR4401's safety and tolerability confirms its potential as a reliable and innovative solution for cholesterol management.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
PROBIOTICS FOR PETS
The Power of Probiotics for Pets
For Gut Health & Weight Management
* This animal experiment was conducted with the approval of the institutional Animal Care and the Use Committee (IACUC) at Chungnam National University
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Ready to find out more?
Drop us a line today for a free quote!
(844) 410-1400 - Toll Free
INGREDIENT HIGHLIGHT